SE405855B - Analogiforfarande for framstellning av piperidinderivat - Google Patents

Analogiforfarande for framstellning av piperidinderivat

Info

Publication number
SE405855B
SE405855B SE7310218A SE7310218A SE405855B SE 405855 B SE405855 B SE 405855B SE 7310218 A SE7310218 A SE 7310218A SE 7310218 A SE7310218 A SE 7310218A SE 405855 B SE405855 B SE 405855B
Authority
SE
Sweden
Prior art keywords
piperidine derivatives
preparing piperidine
analogical procedure
analogical
procedure
Prior art date
Application number
SE7310218A
Other languages
English (en)
Swedish (sv)
Inventor
M Wilhelm
K Eichenberger
H Schroter
F Ostermayer
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of SE405855B publication Critical patent/SE405855B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/75Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50Pyridazines; Hydrogenated pyridazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE7310218A 1972-08-24 1973-07-23 Analogiforfarande for framstellning av piperidinderivat SE405855B (sv)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CH1175675A CH598251A5 (fr) 1972-08-24 1972-08-24
CH1253972A CH574953A5 (fr) 1972-08-24 1972-08-24
CH967073 1973-07-03

Publications (1)

Publication Number Publication Date
SE405855B true SE405855B (sv) 1979-01-08

Family

ID=27176276

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7310218A SE405855B (sv) 1972-08-24 1973-07-23 Analogiforfarande for framstellning av piperidinderivat

Country Status (11)

Country Link
JP (1) JPS4956985A (fr)
AT (1) AT330174B (fr)
BE (1) BE803934A (fr)
CA (1) CA1033736A (fr)
CH (3) CH598251A5 (fr)
DE (1) DE2341229A1 (fr)
FR (1) FR2196809B1 (fr)
GB (2) GB1446222A (fr)
NL (1) NL7311514A (fr)
OA (1) OA04549A (fr)
SE (1) SE405855B (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK141752B (da) * 1974-07-31 1980-06-09 Ciba Geigy Ag Aalogifremgangsmåde til fremstilling af piperidiner eller salte deraf.
EP0000485A1 (fr) * 1977-07-08 1979-02-07 Ciba-Geigy Ag Pipéridino-propanols, leur préparation et compositions pharmaceutiques les contenant
FR2803298A1 (fr) * 1999-12-30 2001-07-06 Adir Nouvelles urees lineaires ou cycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Also Published As

Publication number Publication date
OA04549A (fr) 1980-04-30
CA1033736A (fr) 1978-06-27
GB1441420A (en) 1976-06-30
FR2196809B1 (fr) 1977-06-17
JPS4956985A (fr) 1974-06-03
BE803934A (fr) 1974-02-25
GB1446222A (en) 1976-08-18
FR2196809A1 (fr) 1974-03-22
DE2341229A1 (de) 1974-03-07
CH574953A5 (fr) 1976-04-30
CH574954A5 (fr) 1976-04-30
CH598251A5 (fr) 1978-04-28
NL7311514A (fr) 1974-02-26
ATA733273A (de) 1975-09-15
AU5949573A (en) 1975-02-27
AT330174B (de) 1976-06-25

Similar Documents

Publication Publication Date Title
AR195313A1 (es) Procedimiento para preparar derivados de piperidina sustituidos
SE395366B (sv) Forfarande for framstellning av porosa tabletter
SE400771B (sv) Forfarande for framstellning av 3alfa-hydroxi- och 3alfa-hydroxi-19-norpregnaner
SE413246B (sv) Forfarande for framstellning av kolesteroloxidas
SE417968B (sv) Forfarande for framstellning av penamderivat
SE419339B (sv) Forfarande for framstellning av substituerade sulfonylacetamidocefalosporiner
SE397530B (sv) Forfarande for framstellning av 1-pyrazolylalkyl-4-arylpiperazinderivat
NO139124C (no) Fremgangsmaate for fremstilling av estere
SE420098B (sv) Forfarande for framstellning av linkomycinderivat
SE386894B (sv) Analogiforfarande for framstellning av morfinanderivat
SE423092B (sv) Forfarande for framstellning av vissa 13-tiaprostaglandiner
SE7611202L (sv) Forfarande for framstellning av pyrazolodiazepinforeningar
SE387344B (sv) Forfarande for framstellning av pyrazin-4-oxidderivat
NO139524C (no) Analogifremgangsmaate ved fremstilling av nye d-homosteroider
SE397088B (sv) Forfarande for framstellning av nya 2-propanolderivat
SE419543B (sv) Forfarande for framstellning av vissa angivna isokinolinderivat
SE384510B (sv) Forfarande for framstellning av nya isoindolinpiperazinderivat
SE385581B (sv) Forfarande for framstellning av foretrade n-metylolkarbamidforeningar
SE393376B (sv) Forfarande for framstellning av pyrimidinonderivat
NO138806C (no) Analogifremgangsmaate for fremstilling av neuroleptisk aktive 6-fluor-substituert tiaxanten-derivater
NO140185C (no) Fremgangsmaate til fremstilling av indolderivater
SE402454B (sv) Forfarande for framstellning av 2-alkoxi-5-alkylsulfonyl-toluen
SE405855B (sv) Analogiforfarande for framstellning av piperidinderivat
SE403112B (sv) Analogiforfarande for framstellning av skopolaminderivat
SE415100B (sv) Forfarande for framstellning av kinuklidin-kinolinderivat